The Foundation for AIDS Research (amfAR) has announced a third year of funding for the amfAR Research Consortium on HIV Eradication (ARCHE), according to an amfAR statement. The consortium is directing close to half a million dollars in grants to three scientific teams working on various avenues of AIDS research. These include a study of the drug disulfiram and its ability to flush the virus from latently infected cells; research into the difficulties of mobilizing all copies of HIV in latently infected cells; and an analysis of the recent discovery of identical clones of latent HIV, including what the discovery means for efforts to clear the virus from the body.

To read the amfAR statement, click here.